Singular Health Group Stock Book Value Per Share
| SHG Stock | 0.11 0.01 8.33% |
Singular Health Group fundamentals help investors to digest information that contributes to Singular Health's financial success or failures. It also enables traders to predict the movement of Singular Stock. The fundamental analysis module provides a way to measure Singular Health's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Singular Health stock.
Singular | Book Value Per Share |
Singular Health Group Company Book Value Per Share Analysis
Singular Health's Book Value per Share (B/S) can be calculated by subtracting liabilities from assets, and then dividing it by the total number of currently outstanding shares. It indicates the level of safety associated with each common share after removing the effects of liabilities. In other words, a shareholder can use this ratio to see how much he or she can sell the stake in the company in the event of a liquidation.
More About Book Value Per Share | All Equity Analysis
Book Value per Share | = | Common EquityAverage Shares |
Current Singular Health Book Value Per Share | 0.01 X |
Most of Singular Health's fundamental indicators, such as Book Value Per Share, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Singular Health Group is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The naive approach to look at Book Value per Share is to compare it to current stock price. If Book Value per Share is higher than the currently traded stock price, the company can be considered undervalued. However, investors must be aware that conventional calculation of Book Value does not include intangible assets such as goodwill, intellectual property, trademarks or brands and may not be an appropriate measure for many firms.
| Competition |
Singular Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
In accordance with the recently published financial statements, the book value per share of Singular Health Group is about 0.007 times. This is 100.41% lower than that of the Health Care Technology sector and significantly higher than that of the Health Care industry. The book value per share for all Australia stocks is 100.0% higher than that of the company.
Singular Book Value Per Share Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Singular Health's direct or indirect competition against its Book Value Per Share to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Singular Health could also be used in its relative valuation, which is a method of valuing Singular Health by comparing valuation metrics of similar companies.Singular Health is currently under evaluation in book value per share category among its peers.
Singular Fundamentals
| Return On Equity | -3.83 | ||||
| Return On Asset | -0.72 | ||||
| Operating Margin | (3.31) % | ||||
| Current Valuation | 21.51 M | ||||
| Shares Outstanding | 206.76 M | ||||
| Shares Owned By Insiders | 45.13 % | ||||
| Price To Book | 15.78 X | ||||
| Price To Sales | 24.35 X | ||||
| Revenue | 90.83 K | ||||
| Gross Profit | (71.87 K) | ||||
| EBITDA | (2.89 M) | ||||
| Net Income | (2.88 M) | ||||
| Total Debt | 218.45 K | ||||
| Book Value Per Share | 0.01 X | ||||
| Cash Flow From Operations | (2.44 M) | ||||
| Earnings Per Share | (0.02) X | ||||
| Beta | -0.033 | ||||
| Market Capitalization | 22.74 M | ||||
| Total Asset | 2.35 M | ||||
| Retained Earnings | (20.9 M) | ||||
| Working Capital | (1.7 M) | ||||
| Net Asset | 2.35 M |
About Singular Health Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Singular Health Group's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Singular Health using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Singular Health Group based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Singular Stock Analysis
When running Singular Health's price analysis, check to measure Singular Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Singular Health is operating at the current time. Most of Singular Health's value examination focuses on studying past and present price action to predict the probability of Singular Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Singular Health's price. Additionally, you may evaluate how the addition of Singular Health to your portfolios can decrease your overall portfolio volatility.